Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Más filtros

Bases de datos
Tipo del documento
Intervalo de año de publicación
2.
Am J Health Syst Pharm ; 76(13): 935-942, 2019 Jun 18.
Artículo en Inglés | MEDLINE | ID: mdl-31361890

RESUMEN

PURPOSE: Randomized controlled trials investigating the efficacy and safety of fecal microbiota transplantation (FMT) for recurrent Clostridioides difficile infection (CDI) are reviewed, and practical issues for pharmacists to consider are discussed. SUMMARY: Eight randomized controlled trials evaluating the use of FMT for recurrent CDI were analyzed. The trials varied in the type of sample (fresh, frozen, lyophilized), route of administration (nasogastric tube, colonoscopy, enema, oral), and comparator agent (different type of FMT, vancomycin). Efficacy rates ranged from 43.8% to 96.2% with FMT, and safety data were relatively similar. With these favorable data, pharmacists are likely to be involved at multiple steps in the delivery of FMT to patients with recurrent CDI, including the procurement, documentation, and administration of various products and patient education. CONCLUSION: FMT is an option for recurrent CDI that is supported by findings of randomized controlled trials, although a preferred method for the delivery remains to be defined. Pharmacists can play an important role in the successful management of patients with recurrent CDI who may benefit from FMT.


Asunto(s)
Clostridioides difficile/aislamiento & purificación , Infecciones por Clostridium/terapia , Trasplante de Microbiota Fecal/métodos , Farmacéuticos/organización & administración , Infecciones por Clostridium/microbiología , Trasplante de Microbiota Fecal/efectos adversos , Humanos , Educación del Paciente como Asunto/organización & administración , Rol Profesional , Ensayos Clínicos Controlados Aleatorios como Asunto , Recurrencia , Recolección de Tejidos y Órganos/métodos , Obtención de Tejidos y Órganos/organización & administración , Resultado del Tratamiento
6.
Consult Pharm ; 27(1): 58-65, 2012 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-22231999

RESUMEN

This case reports on a patient whose International Normalized Ratio (INR) increased after ingestion of cranberry sauce while stabilized on warfarin. It is followed by a review of the published literature on the potential interaction between the two.An 85-year-old woman on chronic warfarin therapy for atrial fibrillation experienced INR elevations of two- to three-fold after two separate ingestions of cranberry sauce. In each case, her INR values decreased after withholding three to four doses and resuming a similar maintenance dose of warfarin. Although the majority of the pharmacokinetic and pharmacodynamic studies did not find a significant interaction between cranberry and warfarin, several case reports indicate that cranberry products may increase INR values in patients on warfarin. Practitioners should consider cranberry usage as a potential contributor in the evaluation of supratherapeutic INR values in patients on warfarin.


Asunto(s)
Anticoagulantes/uso terapéutico , Interacciones Alimento-Droga , Vaccinium macrocarpon/efectos adversos , Warfarina/uso terapéutico , Anciano , Anciano de 80 o más Años , Fibrilación Atrial/tratamiento farmacológico , Femenino , Humanos , Relación Normalizada Internacional , Warfarina/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA